Interest in Functional Foods and Supplements GLP-1 drugs may increase consumer interest in functional foods that complement weight management and support overall health
I also think its a superfluous argument (my opinion) and muddies what I hoped the central core of the debate would bethe Carbohydrate-Insulin Model (CIM) of obesity
Nakamura T, Iwanaga Y, Miyaji Y, Nohara R, Ishimura T, Miyazaki S, et al
Insurance typically does not cover GLP-1s for weight loss
3b), which identified the 10 nmol kg 1 dose as the lead concentration for further studies
GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 2030 1 Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs primary side effect Forzet targeting preservation of muscle while on GLP-1 agonist therapy to facilitate continued patient adherence and muscle redevelopment following therapy discontinuation to help mitigate weight regain TAMPA, FLORIDA / ACCESS Newswire / March 9, 2026 / Wellgistics Health, Inc